Luteinising hormone releasing hormone analogues in the treatment of prostate cancer

Author： Gommersall Lyndon M   Hayne Dickon   Shergill Iqbal S   Arya Manit   Wallace DMA  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.3, Iss.12, 2002-12, pp. : 1685-1692

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Luteinising hormone-releasing hormone antagonists in prostate cancer therapy

By Msaouel Pavlos   Diamanti Evanthia   Tzanela Marinela   Koutsilieris Michael  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 2, 2007-05 ,pp. : 285-299

Informa Healthcare

Access to resources Recommend Favorite

Adjuvant Luteinising Hormone-Releasing Hormone (LHRH)--Agonist Therapy in Prostate Cancer

By Kaisary A.V.   Jarmulowicz M.  

UroOncology, Vol. 3, Iss. 2, 2003-06 ,pp. : 51-62

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Agonists of luteinizing hormone-releasing hormone in prostate cancer

By Rick Ferenc G   Block Norman L   Schally Andrew V  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 16, 2013-11 ,pp. : 2237-2247

Informa Healthcare

Access to resources Recommend Favorite

Abarelix: the first gonadotrophin-releasing hormone antagonist for the treatment of prostate cancer

By Mongiat-Artus Pierre   Teillac Pierre  

Expert Opinion on Pharmacotherapy, Vol. 5, Iss. 10, 2004-10 ,pp. : 2171-2179

Informa Healthcare

Access to resources Recommend Favorite

Luteinizing hormone-releasing hormone receptor targeted agents for prostate cancer

By Liu Stephen V   Liu Shanshan   Pinski Jacek  

Expert Opinion on Investigational Drugs, Vol. 20, Iss. 6, 2011-06 ,pp. : 769-778

Informa Healthcare

Access to resources Recommend Favorite